Omega-3 fatty acids and liver disease

被引：54

作者：

Lee, Sang

Gura, Kathleen M.

Puder, Mark

机构：

[1] Harvard Univ, Childrens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA

[2] Harvard Univ, Childrens Hosp, Sch Med, Vasc Biol Program, Boston, MA 02115 USA

[3] Harvard Univ, Childrens Hosp, Sch Med, Dept Pharm, Boston, MA 02115 USA

来源：

HEPATOLOGY | 2007年 / 45卷 / 04期

关键词：

D O I：

10.1002/hep.21645

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：841 / 845

页数：5

共 30 条

[1] Omega-3 fatty acids improve hepatic steatosis in a murine model:: Potential implications for the marginal steatotic liver donor [J].

Alwayn, IPJ ;

Andersson, C ;

Zauscher, B ;

Gura, K ;

Nosé, V ;

Puder, M .

TRANSPLANTATION, 2005, 79 (05) :606-608

[2] Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease [J].

Alwayn, IPJ ;

Gura, K ;

Nosé, V ;

Zausche, B ;

Javid, P ;

Garza, J ;

Verbesey, J ;

Voss, S ;

Ollero, M ;

Andersson, C ;

Bistrian, B ;

Folkman, J ;

Puder, M .

PEDIATRIC RESEARCH, 2005, 57 (03) :445-452

[3] Nonalcoholic fatty liver disease [J].

Brunt, Elizabeth M. ;

Wong, Vincent W. -S. ;

Nobili, Valerio ;

Day, Christopher P. ;

Sookoian, Silvia ;

Maher, Jacquelyn J. ;

Bugianesi, Elisabetta ;

Sirlin, Claude B. ;

Neuschwander-Tetri, BrentA. ;

Rinella, Mary E. .

NATURE REVIEWS DISEASE PRIMERS, 2015, 1

[4] Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 [J].

Arita, M ;

Bianchini, F ;

Aliberti, J ;

Sher, A ;

Chiang, N ;

Hong, S ;

Yang, R ;

Petasis, NA ;

Serhan, CN .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :713-722

[5] Eicosapentaenoic acid (EPA):: An antiinflammatory ω-3 fat with potential clinical applications [J].

Babcock, T ;

Helton, WS ;

Espat, NJ .

NUTRITION, 2000, 16 (11-12) :1116-1118

[6] Prevalence of and risk factors for hepatic steatosis in northern Italy [J].

Bellentani, S ;

Saccoccio, G ;

Masutti, F ;

Crocè, LS ;

Brandi, G ;

Sasso, F ;

Cristanini, G ;

Tiribelli, C .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :112-117

[7] Inhibition of inflammatory response in transgenic fat-1 mice on a calorie-restricted diet [J].

Bhattacharya, Arunabh ;

Chandrasekar, Bysani ;

Rahman, Md Mizanur ;

Banu, Jameela ;

Kang, Jing X. ;

Fernandes, Gabriel .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 349 (03) :925-930

[8] Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study [J].

Capanni, M ;

Calella, F ;

Biagini, MR ;

Genise, S ;

Raimondi, L ;

Bedogni, G ;

Svegliati-Baroni, G ;

Sofi, F ;

Milani, S ;

Abbate, R ;

Surrenti, C ;

Casini, A .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) :1143-1151

[9] Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies [J].

Clark, JM ;

Diehl, AM .

GASTROENTEROLOGY, 2003, 124 (01) :248-250

[10] How different is the dietary pattern in non-alcoholic steatohepatitis patients? [J].

Cortez-Pinto, H. ;

Jesus, L. ;

Barros, H. ;

Lopes, C. ;

Moura, M. C. ;

Camilo, M. E. .

CLINICAL NUTRITION, 2006, 25 (05) :816-823

← 1 2 3 →